skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:045161/0825   Pages: 7
Recorded: 03/09/2018
Attorney Dkt #:CLFR.P0001
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 15
1
Patent #:
Issue Dt:
10/10/1995
Application #:
08061471
Filing Dt:
05/17/1993
Title:
INHIBITION OF NITRIC OXIDE PRODUCTION BY RETINOIC ACID
2
Patent #:
Issue Dt:
08/19/1997
Application #:
08346626
Filing Dt:
11/30/1994
Title:
INHIBITION OF TUMOR NECROSIS FACTOR BY RETINOIC ACID
3
Patent #:
Issue Dt:
07/29/2003
Application #:
09026882
Filing Dt:
02/19/1998
Title:
IMMUNOTOXINS DIRECTED AGAINST CD33 RELATED SURFACE ANTIGENS
4
Patent #:
Issue Dt:
05/29/2007
Application #:
09226895
Filing Dt:
01/07/1999
Title:
POTENTIATION OF ANTI-CD38-IMMUNOTOXIN CYTOTOXICITY
5
Patent #:
Issue Dt:
08/12/2003
Application #:
09375907
Filing Dt:
08/17/1999
Title:
USES OF TRANK, A NOVEL SECRETORY CYTOKINE
6
Patent #:
Issue Dt:
11/20/2007
Application #:
10386204
Filing Dt:
03/11/2003
Publication #:
Pub Dt:
08/21/2003
Title:
IMMUNOTOXINS DIRECTED AGAINST CD33 RELATED SURFACE ANTIGENS
7
Patent #:
NONE
Issue Dt:
Application #:
10846022
Filing Dt:
05/14/2004
Publication #:
Pub Dt:
12/09/2004
Title:
Vascular endothelial growth factor fusion constructs and uses thereof
8
Patent #:
Issue Dt:
10/13/2009
Application #:
10919193
Filing Dt:
08/16/2004
Publication #:
Pub Dt:
02/17/2005
Title:
Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis
9
Patent #:
Issue Dt:
12/09/2008
Application #:
10925608
Filing Dt:
08/25/2004
Publication #:
Pub Dt:
04/14/2005
Title:
OSTEOCLASTOGENESIS INHIBITORS AND USES THEREOF
10
Patent #:
Issue Dt:
05/06/2008
Application #:
10981082
Filing Dt:
11/04/2004
Publication #:
Pub Dt:
09/15/2005
Title:
SELECTIVE INHIBITORS OF NUCLEAR FACTOR-KAPPAB ACTIVATION AND USES THEREOF
11
Patent #:
NONE
Issue Dt:
Application #:
11179321
Filing Dt:
07/12/2005
Publication #:
Pub Dt:
01/26/2006
Title:
Guggulsterone: an inhibitor of nuclear factor - kappaB and IkappaBalpha kinase activation and uses thereof
12
Patent #:
NONE
Issue Dt:
Application #:
11329362
Filing Dt:
01/10/2006
Publication #:
Pub Dt:
11/23/2006
Title:
Targeted chimeric molecules for cancer therapy
13
Patent #:
NONE
Issue Dt:
Application #:
11868801
Filing Dt:
10/08/2007
Publication #:
Pub Dt:
04/17/2008
Title:
Immunotoxins directed against CD33 related surface antigens
14
Patent #:
NONE
Issue Dt:
Application #:
12055164
Filing Dt:
03/25/2008
Publication #:
Pub Dt:
04/30/2009
Title:
Selective Inhibitors of Nuclear Factor KappaB Activation and Uses Thereof
15
Patent #:
NONE
Issue Dt:
Application #:
12552103
Filing Dt:
09/01/2009
Publication #:
Pub Dt:
03/18/2010
Title:
METHODS OF TREATING BONE DISEASE USING VASCULAR ENDOTHELIAL GROWTH FACTOR FUSION CONSTRUCTS
Assignor
1
Exec Dt:
03/09/2018
Assignee
1
210 WEST 7TH STREET
AUSTIN, TEXAS 78701
Correspondence name and address
PARKER HIGHLANDER PLLC
1120 S. CAPITAL OF TEXAS HWY.
BUILDING ONE, SUITE 200
AUSTIN, TX 78746

Search Results as of: 05/22/2024 10:06 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT